Marigold
The inflorescences of this plant originating in Europe are used.
It contains polysaccharides, flavonoids, saponins…
Attributed properties which do not have sufficient clinical evidence to support them: healing agent, antiseptic, anti-inflammatory (local, dermatological). There is no evidence of its efficacy when taken orally to treat gastrointestinal disorders.
Indications from the Commission E of the German Ministry of Health and the EMA: topical treatment of minor skin inflammations, ulcers and burns.
Since the last update we have not found any published data on its excretion in breast milk.
A plant devoid of toxicity. Oral use during breastfeeding is not advised (EMA 2008, Amir 2011).
The small dose and poor plasma uptake of most topical dermatological preparations make it very unlikely that significant amounts will pass into breast milk.
There is no evidence of its effectiveness in treating nipple cracking or inflammation.
If applied to the breast, do so after breastfeeding and clean before the next feed.
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Synonyms
- Calendula
- Chinese safflower
- Feminell
- Gold-Bloom
- Marigold
- Marybud
- Ruddes
Writings
- Calendula officinalis (Latin, botanical name)
- Ноготки (Cyrillic)
Drug trade names
References
- WHO. World Health Organization. WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). WHO monographs. 2010 Full text (in our servers)
- EMA. Calendula officinalis. Community herbal monographs. 2008 Full text (in our servers)
- WHO. World Health Organization. Geneva. WHO monographs on selected medicinal plants. Volume 2. WHO monographs. 1999 Full text (link to original source) Full text (in our servers)